Skip to main content

Want a detailed portfolio tracker?

Eyenovia (HYPD) P/E (2018 - 2026)

Eyenovia (HYPD) P/E from Apr 2, 2018 to Jul 21, 2026. The TTM Eyenovia (HYPD) P/E is -0.59. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Eyenovia (HYPD)

YearP/EChange
2026-0.59+10.76%
2025-0.53+150.32%
2024-0.21-93.32%
2023-3.19+7.21%
2022-2.98-62.43%
2021-7.92+17.73%
2020-6.73+127.34%
2019-2.96+70.73%
2018-1.73N/A

Comparison Eyenovia (HYPD) P/E with competitors

Eyenovia (HYPD) P/E is -0.59.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.29%
NBYStablecoin Development Corp0.00-100.73%
ENLVEnlivex Ltd0.07-112.66%
FGENFibroGen Inc0.24-140.64%
CHRSCoherus Biosciences Inc0.85-243.65%
FBIOFortress Biotech Inc0.95-260.66%
ORMPOramed Pharmaceuticals Inc1.50-354.45%
AGENAgenus Inc3.01-609.50%
INVAInnoviva Inc3.15-633.95%
VXRTVaxart Inc3.55-700.94%
CRMDCorMedix Inc3.63-714.26%
CVACCureVac N.V.4.45-852.61%
GLPGGalapagos NV4.86-922.57%
SRPTSarepta Therapeutics Inc4.88-926.50%
ABEOAbeona Therapeutics Inc5.39-1012.06%
ABUSArbutus Biopharma Corp5.60-1047.29%
ZVRAZevra Therapeutics Inc5.89-1096.66%
SPROSpero Therapeutics Inc6.23-1154.42%
CGENCompugen Ltd6.31-1168.90%
RIGLRigel Pharmaceuticals6.87-1263.38%
SLXNSilexion Therapeutics Corp7.30-1335.16%
OMEROmeros Corporation9.26-1667.43%
AUPHAurinia Pharmaceuticals Inc9.58-1722.65%
PLXProtalix BioTherapeutics Inc10.89-1943.76%
ACADAcadia Pharmaceuticals Inc11.73-2085.54%
TBPHTheravance Biopharma Inc12.26-2175.88%
ADMAAdma Biologics Inc12.42-2202.29%
HRMYHarmony Biosciences Holdings Inc13.82-2439.65%
SABSSAB Biotherapeutics Inc14.14-2493.15%
NAGENiagen Bioscience Inc14.82-2608.59%
INCYIncyte Corp15.82-2778.63%
REGNRegeneron Pharmaceuticals Inc15.86-2784.41%
PBYIPuma Biotechnology Inc17.32-3031.41%
CPRXCatalyst Pharmaceuticals Inc17.44-3052.34%
EXELExelixis Inc17.54-3069.05%
TGTXTG Therapeutics Inc18.97-3310.80%
MDXGMimedx Group Inc20.55-3579.38%
XOMAXOMA Royalty Corp22.87-3972.61%
ARGXArgen X SE24.30-4213.57%
CTMXCytomX Therapeutics Inc24.82-4302.13%
XOMAOXOMA Royalty Corp25.34-4390.79%
HALOHalozyme Therapeutics Inc25.62-4438.01%
XOMAPXOMA Royalty Corp25.67-4445.86%
VRTXVertex Pharmaceuticals Inc27.99-4839.41%
RPRXRoyalty Pharma plc - Class A28.69-4956.70%
SLNOSoleno Therapeutics Inc29.02-5012.20%
ASNDAscendis Pharma A/S30.09-5193.38%
LGNDLigand Pharmaceuticals Inc - Class B37.91-6518.38%
APLSApellis Pharmaceuticals Inc39.02-6706.16%
BMRNBiomarin Pharmaceutical Inc42.21-7246.32%
KRYSKrystal Biotech Inc45.34-7776.50%
ONCBeiGene Ltd69.54-11872.97%
PHARPharming Group N.V.75.03-12801.58%
TECHBio-Techne Corp101.96-17361.22%
VCELVericel Corp109.92-18709.32%
ALNYAlnylam Pharmaceuticals Inc117.96-20071.11%
GMABGenmab140.29-23850.77%
TLXTelix Pharmaceuticals Ltd162.15-27551.95%
CORTCorcept Therapeutics Inc212.86-36136.09%